< Back to search
Filter
1

A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Haven CT, New York NY, Durham NC, Cleveland OH,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06859762

Phase1, Recruiting

A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors

for
Advanced-stage Solid Tumors
Location: Orlando FL, Irving TX
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07223125

Phase1, Recruiting

First-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor Malignancies

for
Participants With Advanced Solid Tumor Malignancies
Location: Fairfax VA, Grand Rapids MI, Houston TX, San Antonio TX,
Sponsor: VelaVigo Bio Inc

Sex: All

Age: 18+

Code: NCT07136779

Phase1, Phase2, Recruiting

Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

for
Advanced Solid Tumor
Location: Nashville TN, Scottsdale AZ
Sponsor: Strand Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT07751042

Phase1, Phase2, Recruiting

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Fairfax VA, Huntersville NC, San Antonio TX
Sponsor: Arvinas Inc.

Sex: All

Age: 18+

Code: NCT07749586

Phase1, Phase2, Recruiting

Interested in new solid tumor trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Haven CT, New York NY, Toronto, San Antonio TX
Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All

Age: 18+

Code: NCT07166601

Phase1, Recruiting

A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies

for
Solid Tumor Malignancies
Location: Fairfax VA, Miami FL, Cincinnati OH, Grand Rapids MI,
Sponsor: Kumquat Biosciences Inc.

Sex: All

Age: 18+

Code: NCT07207707

Phase1, Recruiting

Psychotherapy Intervention for Latinos With Advanced Cancer

for
Solid Tumor, Solid Tumor, Adult,
Location: The Bronx NY, New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT04015609

Recruiting

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

for
Advanced/Metastatic Solid Tumors, Bladder Cancer,
Location: Boston MA, Newton MA, New Haven CT, Trumbull CT,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07090499

Phase1, Recruiting

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

for
Solid Tumor Cancer, Locally Advanced, Metastatic Solid Tumors,
Location: Boston MA, New York NY, Houston TX, Austin TX,
Sponsor: Avenzo Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07193511

Phase1, Phase2, Recruiting

TLN-372 in Advanced KRAS Mutant Solid Tumors

for
KRAS Mutant Solid Tumors
Location: Boston MA, New York NY, Toronto, Grand Rapids MI,
Sponsor: Treeline Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07204340

Phase1, Recruiting

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor, Prostate Cancer,
Location: New York NY, Philadelphia PA, Lake Mary FL,
Sponsor: MOMA Therapeutics

Sex: All

Age: 18+

Code: NCT06545942

Phase1, Recruiting

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic Solid Tumors,
Location: San Antonio TX, Scottsdale AZ
Sponsor: SHY Therapeutics

Sex: All

Age: 18+

Code: NCT07705334

Phase1, Recruiting

Intratumoral N17350 in Advanced Solid Tumors

for
Neoplasms, Solid Tumor, Breast Neoplasms, Triple-Negative,
Location: Buffalo NY
Sponsor: Onchilles Pharma Inc

Sex: All

Age: 18+

Code: NCT07339176

Phase1, Phase2, Recruiting

Gene Therapy for HER-Positive Cancer (SENTRY-HER2)

for
HER2 Expressing Solid Tumors
Location: New York NY, Hackensack NJ, Philadelphia PA,
Sponsor: Vironexis Biotherapeutics Inc.

Sex: All

Age: 18+

Code: NCT07192432

Phase1, Phase2, Recruiting

A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Irving TX, Los Angeles CA
Sponsor: CStone Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06741644

Phase1, Phase2, Recruiting

ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu

for
Solid Tumor, Adult, Malignant Solid Tumor,
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT06824363

Early_phase1, Recruiting

PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer

for
Triple Negative Breast Cancer (TNBC),
Location: Toronto, Houston TX, San Antonio TX,
Sponsor: ProteinQure Inc.

Sex: All

Age: 18+

Code: NCT07190469

Phase1, Recruiting

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Boston MA, New York NY, Hackensack NJ, Buffalo NY,
Sponsor: NextCure, Inc.

Sex: All

Age: 18+

Code: NCT06792552

Phase1, Recruiting

A Study of DS5361b in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Providence RI, Fairfax VA, Sarasota FL, Irving TX,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT07182591

Phase1, Recruiting